- Genetic engineering is now defined by CRISPR-Cas9 genome editing, invented in 2009 and recognised with the 2020 Nobel Prize in Chemistry
- In December 2023 the FDA approved Casgevy, the first CRISPR-based gene therapy, for sickle cell disease, and its use was later broadened to younger children
- In India, undergraduate entry to top biotechnology and genetic engineering programmes runs through JEE Main and JEE Advanced, while postgraduate admission uses GATE.
Genetic engineering is the branch of science that deals with DNA and genes. Scientists in the field reconstruct and redesign the characteristics of an organism, and their work now underpins breakthroughs in medicine, agriculture, and research across the world.
What Is Genetic Engineering?
Genetic engineering is the branch of science that directly manipulates an organism's DNA and genes to reconstruct or redesign its characteristics. A part of the broader field of biotechnology, it lets scientists add, remove, or alter genetic material at precise locations, powering advances across medicine, agriculture, and fundamental research worldwide.
Genetic engineering is a part of the broader field called biotechnology. Modern genome-editing tools act like molecular scissors, letting researchers add, remove, or alter genetic material at precise locations in an organism's DNA, from the simplest bacteria to human cells.
Biotechnology: Scope, Courses and CareersRead →How Is Genetic Engineering Used in Medicine and Agriculture?
In medicine, genetic engineering enables cheaper pharmaceuticals, disease-pandemic responses, and gene therapies that correct hereditary conditions. In agriculture, it produces genetically modified crops with higher yields, enhanced nutrition, and disease resistance while cutting harmful pesticide use. These applications improve food security and reduce production costs for economies around the world today.
In medicine, genetic engineering supports the manufacturing of medicines and other pharmaceuticals at lower cost and helps the world respond to disease pandemics. Its concepts are used to modify and correct genes that can prevent hereditary diseases, and engineered enzymes are making the chemical industry safer and more sustainable.
In agriculture, genetic engineering produces genetically modified crops, fruits, and vegetables that raise crop yields and strengthen food security. It reduces reliance on harmful pesticides and insecticides, enhances nutrition, and makes crops disease resistant, contributing to substantial cost reductions for economies worldwide.
Genetic engineering also offers vast scope for research and development. The genes of organisms from the simplest to the most complex are studied in fine detail, and the DNA of a bacterium is researched as thoroughly as the DNA of a human being.
Top Engineering Programs AbroadRead →Which Courses and Entrance Exams Lead to a Genetic Engineering Career?
Aspirants can pursue BE, B.Tech, or B.Sc in genetic engineering after a science-stream 10+2, followed by ME, M.Tech, or M.Sc. Undergraduate admission to top Indian institutes runs mainly through JEE Main and JEE Advanced, while postgraduate entry uses GATE. Many graduates later pursue a PhD toward research careers.
Candidates interested in genetic engineering can opt for undergraduate courses such as a Bachelor of Engineering in genetic engineering, B.Tech, or B.Sc. These are commonly followed by postgraduate degrees like an ME, M.Tech, or M.Sc, and a range of specializations is available.
- Clinical genetics
- Behavioral genetics
- Classical genetics
- Genomics
- Quantitative and ecological genetics
- Molecular genetics
- Genetic algorithms
Eligibility depends on 10+2 scores in the science stream. For undergraduate admission, JEE Main and JEE Advanced are the most widely accepted entrance examinations at India's top institutes, while GATE is the standard route for postgraduate courses. Many candidates later pursue a PhD to become scientists or professors.
GATE: Graduate Aptitude Test in EngineeringRead →Which Are the Top Institutes for Genetic Engineering?
In India, leading options include IIT Kharagpur, IIT Madras, and IIT Delhi (Biotechnology and Biochemical Engineering), plus the Indian Institute of Science, Bangalore. Abroad, strong programs run at the University of Pennsylvania, UT Austin, Duke, Johns Hopkins, Harvard, and Columbia. Admission is intensely competitive and research-focused at every one of these institutions.
The top institutes in India offering genetic engineering and biotechnology include the Indian Institutes of Technology at Kharagpur, Madras, and Delhi, the Indian Institute of Science in Bangalore, and the All India Institute of Medical Sciences in New Delhi.
Abroad, leading programs in biotechnology and genetic engineering run at the University of Pennsylvania, the University of Texas at Austin, Duke University, Johns Hopkins University, Harvard University, the University of Massachusetts, Oregon State University, Case Western Reserve University, and Columbia University.
| Institute 2026 | Location | Programme and Entry Route |
|---|---|---|
| IIT Kharagpur | Kharagpur, India | B.Tech Biotechnology and Biochemical Engineering (JEE Advanced) |
| IIT Madras | Chennai, India | B.Tech Biological Engineering (JEE Advanced); M.Tech (GATE) |
| IIT Delhi | New Delhi, India | B.Tech Biotechnology and Biochemical Engineering (JEE Advanced) |
| Indian Institute of Science | Bengaluru, India | Research programmes in biological sciences |
| University of Pennsylvania | Philadelphia, USA | Bioengineering and genetics |
What Are the Latest 2026 Developments in Genetic Engineering?
The field's biggest leap is CRISPR-Cas9 genome editing, invented in 2009, which is faster, cheaper, and more precise than older methods. In December 2023 the FDA approved Casgevy, the first CRISPR-based therapy, to treat sickle cell disease, with its use later broadened to younger children. Genome editing has now reached real clinical practice worldwide.
The defining modern technology is CRISPR-Cas9, a genome-editing system adapted from a natural bacterial defence and recognised with the 2020 Nobel Prize in Chemistry. It is faster, cheaper, and more precise than earlier methods. In December 2023 the FDA approved Casgevy, the first CRISPR-based gene therapy, for sickle cell disease, marking genome editing's arrival in mainstream clinical care.